Moderna Inc.’s stock erased early losses to trade up 1.2% Friday, after the biotech company posted a wider-than-expected fourth-quarter loss and offered soft guidance for 2025, offsetting a revenue ...
One of the keys to the Steelers' 2025 season will be the improvement of the team's young offensive line. In the past two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback